Liver in schizophrenic patient after long-term risperidone treatment - Case report;Zaburzenia funkcji wa̧jroby w przebiegu długotrwałego leczenia risperidonem u chorego na schizofreniȩ - Opis przypadku

Psychiatria Polska

Volumn 39, Issue 2, 2005, Pages 309-313

  Radzik, Jacek ^a   Grotthus, Bartosz ^a   Leszek, Jerzy ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Liver dysfunction; Risperidone

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATYPICAL ANTIPSYCHOTIC AGENT; BILIRUBIN; OLANZAPINE; RISPERIDONE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CASE REPORT; CHRONIC DISEASE; HUMAN; JAUNDICE; LIVER FUNCTION TEST; LIVER TOXICITY; LONG TERM CARE; MALE; MENTAL DISEASE; PRURITUS; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; SCHIZOPHRENIA; TOXIC HEPATITIS; TREATMENT OUTCOME; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; LIVER; LIVER DISEASE; MIDDLE AGED; PARANOID SCHIZOPHRENIA; TIME;

ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; HUMANS; JAUNDICE; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PRURITUS; RISPERIDONE; SCHIZOPHRENIA, PARANOID; TIME FACTORS;

EID: 17144414869     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Konturek S. Gastroenterologia i hepatologia kliniczna. Warszawa: PZWL; 2001, s.604-607.
2. Selim K, Kaplowitz N. Hepatotoxity of psychotropic drugs. Hepatol. 1999; 29: 1347-1351.
3. Whitworth A, Liensberger D, Fleischhacker W. Transient increase of liver enzymes induced by risperidone: two case reports. J. Clin. Psychopharmacol. 1999; 19: 475-476.
4. Cordeiro Q, Elkis H. Pancreatitis and cholestatic hepatitis induced by risperidone. J. Clin. Psychopharmacol. 2001; 21: 529-530.
5. Fuller M, Simon M, Freedman L. Risperidone-associated hepatotoxicity. J. Clin. Psychopharmacol. 1996; 16: 84-85.
6. Szigethy E, Wiznitzer M, Branicky L, Maxwell K, Findling R. Risperidone-induced hepatotoxicity in children and adolescents? A chart review study. J. Child. Adolesc. Psychopharmacol. 1999; 9: 93-98.
7. Benazzi F. Risperidone-induced hepatotoxicity. Pharmacopsychiatry 1998; 31: 241.
8. Krebs S, Dormann H, Muth-Selbach U, Hahn E, Brune K, Schneider H. Risperidone-induced cholestatic hepatitis. Eur. J. Gastroenterol. Hepatol. 2001; 13: 67-69.
9. Szela̧g A. Patomechanizmy hepatotoksycznego działania leków. Gastroenterol. Pol. 2003; 10: 425-429.
10. Landau J, Martin A. Is liver function monitoring warranted during risperidone treatment? J. Am. Acad. Child. Adolesc. Psychiatr. 1998; 37: 1007-1008.